AR048167A1 - Suplemento dietetico con cantidades estequiometricamente especificas de citrato de potasio y magnesio - Google Patents

Suplemento dietetico con cantidades estequiometricamente especificas de citrato de potasio y magnesio

Info

Publication number
AR048167A1
AR048167A1 ARP050100874A ARP050100874A AR048167A1 AR 048167 A1 AR048167 A1 AR 048167A1 AR P050100874 A ARP050100874 A AR P050100874A AR P050100874 A ARP050100874 A AR P050100874A AR 048167 A1 AR048167 A1 AR 048167A1
Authority
AR
Argentina
Prior art keywords
potassium
dietary supplement
estequiometrically
specifications
magnesium citrate
Prior art date
Application number
ARP050100874A
Other languages
English (en)
Original Assignee
Mission Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34912611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR048167(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mission Pharma Co filed Critical Mission Pharma Co
Publication of AR048167A1 publication Critical patent/AR048167A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265Citric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una forma específica de una sal mineral doble que contiene potasio, magnesio y citrato en una relacion estequiométrica de potasio:magnesio menor que 4:1. También se describen métodos para elaborar la composicion y utilizar dicha composicion como un suplemento dietético.
ARP050100874A 2004-03-08 2005-03-08 Suplemento dietetico con cantidades estequiometricamente especificas de citrato de potasio y magnesio AR048167A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/797,321 US7091246B2 (en) 2004-03-08 2004-03-08 Dietary supplementation with stoichiometrically specific potassium magnesium citrate

Publications (1)

Publication Number Publication Date
AR048167A1 true AR048167A1 (es) 2006-04-05

Family

ID=34912611

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100874A AR048167A1 (es) 2004-03-08 2005-03-08 Suplemento dietetico con cantidades estequiometricamente especificas de citrato de potasio y magnesio

Country Status (10)

Country Link
US (1) US7091246B2 (es)
EP (1) EP1722772A4 (es)
AR (1) AR048167A1 (es)
AU (1) AU2005221662B2 (es)
MX (1) MXPA06010133A (es)
MY (1) MY136877A (es)
NO (1) NO20064085L (es)
PE (1) PE20061101A1 (es)
TW (1) TWI282274B (es)
WO (1) WO2005087218A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10251909B2 (en) * 2007-02-09 2019-04-09 Board Of Regents, The University Of Texas System Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension
IL191876A (en) * 2008-06-02 2013-12-31 Gadot Biochemical Ind Ltd Potassium magnesium citrate, a process for its preparation and use
US8859824B2 (en) * 2009-01-22 2014-10-14 Mission Pharmacal Company Dual cation dual anion coordination complexes
DE102010053748B4 (de) * 2010-12-08 2023-08-03 Jörg Schierholz Pharmazeutische Zusammensetzung zur Behandlung von Übergewicht
US10285961B2 (en) 2014-02-06 2019-05-14 University Of Houston System Organic acids as agents to dissolve calcium minerals in pathological calcification and uses thereof
RS60272B1 (sr) * 2015-09-14 2020-06-30 Podravka D D Zamena za so i njena primena
CN110398514B (zh) * 2018-04-24 2023-04-28 恒天纤维集团有限公司 一种快速判断纤维素胶液中金属杂质含量的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE968843C (de) * 1953-11-29 1958-04-03 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von pharmakologisch wirksamen Magnesiumsalzen der Citronensaeure
US4895980A (en) * 1988-01-05 1990-01-23 Mission Pharmacal Company, Inc. Method of manufacturing magnesium potassium citrate
US4985593A (en) * 1988-01-05 1991-01-15 Mission Pharmacal Company, Inc. Magnesium potassium citrate
US5219889A (en) * 1988-01-05 1993-06-15 The University Of Texas System Dietary supplementation with potassium magnesium citrate
CA1326040C (en) * 1989-11-16 1994-01-11 Neill B. Walsdorf Magnesium-potassium citrate
US6514537B1 (en) * 2000-06-02 2003-02-04 Cumberland Swan Holdings, Inc. Magnesium citrate solution
CN1486969A (zh) * 2003-08-13 2004-04-07 南京市鼓楼医院 枸橼酸氢钾镁复合矿物盐及制备方法

Also Published As

Publication number Publication date
WO2005087218A1 (en) 2005-09-22
TWI282274B (en) 2007-06-11
US20050197402A1 (en) 2005-09-08
TW200531681A (en) 2005-10-01
PE20061101A1 (es) 2007-01-03
MY136877A (en) 2008-11-28
AU2005221662A1 (en) 2005-09-22
MXPA06010133A (es) 2007-03-21
AU2005221662B2 (en) 2008-04-17
EP1722772A4 (en) 2008-03-19
US7091246B2 (en) 2006-08-15
NO20064085L (no) 2006-12-07
EP1722772A1 (en) 2006-11-22

Similar Documents

Publication Publication Date Title
AR048167A1 (es) Suplemento dietetico con cantidades estequiometricamente especificas de citrato de potasio y magnesio
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
BRPI0620425B8 (pt) composição para nutrição parenteral, método para preparar a mesma, uso, e, kit
ZA200703115B (en) Dimensionally stable low carbohydrate pet food
CA125601S (en) Bottle with topical composition
CA120236S (en) Detachable bootie with garment
AU316079S (en) A container
AU324507S (en) Track shoe for endless-track vehicle
TW200806221A (en) Method of relating different products by a common feature
CU23776B7 (es) Composiciones con suplemento de hierro con tolerancia mejorada
AR111471A2 (es) Composición de combinación sinérgica
CA121128S (en) Container
CA114551S (en) Closure
AR059577A1 (es) Agente de aceleracion de absorcion del calcio
JO2394B1 (en) Dietary additives with limited equivalent amounts of potassium magnesium citrate
AU303867S (en) Left boot
AU303865S (en) Left boot
MXPA05008219A (es) Composiciones y metodos para tratar condiciones de la piel.
AU321054S (en) Urban ashtray double face
AU300795S (en) A floor waste grate
AU303100S (en) Crate and blank therefor
AU309268S (en) Double wheel
AU302594S (en) Easy-open carton blank
AU302587S (en) Easy-open carton blank
AU302589S (en) Easy-open carton blank

Legal Events

Date Code Title Description
FB Suspension of granting procedure